Status:
RECRUITING
Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CT
Lead Sponsor:
Post Graduate Institute of Medical Education and Research, Chandigarh
Collaborating Sponsors:
Ministry of Science and Technology, India
Conditions:
Cushing Syndrome
Eligibility:
All Genders
5-75 years
Brief Summary
The incidence of Cushing syndrome (CS) is 1.2-3.2 cases per million per year, of which adrenocorticotropic Hormone (ACTH)-dependent disease comprises approximately 70-80% of cases. Among these, nearly...
Detailed Description
Cushing's syndrome (CS) is one of the most enigmatic endocrine disorders. It is important to confirm the adrenocorticotropic Hormone (ACTH) dependent hypercortisolism and distinguishing Cushing's dise...
Eligibility Criteria
Inclusion
- Patients diagnosed with endogenous Cushing's syndrome
- Patients in the age group of 5 to 75 years.
- Patients willing to give informed consent.
Exclusion
- Patient with exogenous exposure to steroids
- Ongoing pregnancy
- Severe comorbid conditions that may interfere with the study.
Key Trial Info
Start Date :
August 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06962202
Start Date
August 15 2022
End Date
October 1 2025
Last Update
May 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Post Graduate Institute of Medical Sciences
Chandigarh, India, 160012